Brightcove Inc (NASDAQ:BCOV) had its price target decreased by RBC Capital from $16.00 to $13.00 in a research note issued to investors. The firm currently has an outperform rating on the stock. Brightcove Inc (NASDAQ:BCOV) stock performance was -6.69% in last session and finished the day at $7.95. Traded volume was 818.42K shares in the…
China Hgs Real Estate Inc (NASDAQ:HGSH), a leading regional real estate developer headquartered in Hanzhong City, Shaanxi Province, China, today announced that the Hanzhong government accepted the delivery of the two municipal roads that were constructed by the Company on March 21, 2014. China Hgs Real Estate Inc (NASDAQ:HGSH) stock performance was 0.97% in last…
IFM Investments Limited (ADR) (NYSE:CTC), a leading comprehensive real estate services provider and the exclusive franchisor for the CENTURY 21® brand in China, announced that it has received the Shanghai Real Estate Brokerage Industry Association’s “Golden Bridge Award” for the tenth consecutive year. IFM Investments Limited (ADR) (NYSE:CTC) stock performance was with no change in…
Synageva BioPharma Corp (NASDAQ:GEVA) last released its earnings data on Friday, May 2nd. The company reported ($1.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.19) by $0.03. Analysts expect that Synageva BioPharma Corp will post $-5.90 EPS for the current fiscal year. Synageva BioPharma Corp (NASDAQ:GEVA)stock performance was 5.87% in…
VIVUS (NASDAQ:VVUS) last posted its quarterly earnings results on Monday, February 24th. The company reported ($0.17) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.40) by $0.23. VIVUS, Inc. (NASDAQ:VVUS)stock performance was 3.34% in last session and finished the day at $ 5.26. Traded volume was 2,821,422 shares in the last…
Endocyte (NASDAQ:ECYT)’s shares saw strong trading volume on Friday after the company announced better than expected quarterly earnings, American Banking and Market News reports. 13,778,961 shares changed hands during trading, an increase of 624% from the previous session’s volume of 1,903,723 shares. Endocyte, Inc. (NASDAQ:ECYT) stock performance was 61.91% in last session and finished the…
Tech Analysis & Market News